Obstetrics & Gynecology Doctors in Gresham, OR Accepting Medicare

8 Obstetrics & Gynecology doctors found. Showing 1 - 8

Dr. Daniel Marvin Patchin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4215 Se Regner Rd, Gresham, OR 97080 Phone: 503-665-8500

Dr. Kelly Annette Carter, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 24850 Se Stark St, Suite 200, Gresham, OR 97030 Phone: 503-661-0464    Fax: 503-661-1420

Renee Nicole Goodreau, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 24800 Se Stark St, Gresham, OR 97030 Phone: 503-674-1750

Audra Rachelle Norris-jacob, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 24850 Se Stark St Ste 200, Gresham, OR 97030 Phone: 503-491-9444

Sandra Ann Collis, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 24850 Se Stark St, Suite 200, Gresham, OR 97030 Phone: 503-491-9444    Fax: 503-661-1420

Dr. Marilynn Janice Denson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 24800 Se Stark St, Gresham, OR 97030 Phone: 503-491-9444

Michelle Cecile Champagne, CNM Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 24850 Se Stark St, Suite 200, Gresham, OR 97030 Phone: 503-491-9444    Fax: 503-661-1420

Ms. Monica Elizabeth Venn, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 24850 Se Stark St Ste 200, Gresham, OR 97030 Phone: 503-491-9444

News Archive

Obesity epidemic in Britain blamed on society

According to a new report by a government think-tank in Britain the current obesity epidemic is the result of modern life and individuals cannot be blamed for being obese due to overeating and lack of exercise.

Potential hypophosphatasia therapy discovered

Researchers at the Burnham Institute for Medical Research, led by José Luis Millán, Ph.D., have demonstrated in mice the first successful use of enzyme replacement therapy to prevent hypophosphatasia (HPP), a primary skeletal disease of genetic origin. This discovery lays the foundation for future clinical trials for HPP patients.

Genetic risk for mental illness linked to substance use and addiction

There are many reports of drug use leading to mental health problems, and we all know of someone having a few too many drinks to cope with a bad day.

Wolters Kluwer Health enters distribution agreement with NEJM

Wolters Kluwer Health today announced it has entered into an expanded distribution agreement with the New England Journal of Medicine (NEJM), the "gold standard" for quality biomedical research and for the best practices in clinical medicine.

Phase III clinical trial results of DAR-31 published

Gilead Sciences, Inc. today announced the publication of data from DAR-311 (DORADO), a Phase III clinical trial evaluating the company's once-daily oral endothelin receptor antagonist (ERA) darusentan as an add-on treatment for resistant hypertension, defined as the failure to achieve blood pressure goal while adhering to full doses of an appropriate three (or more) drug antihypertensive regimen that includes a diuretic.

Read more Medical News

› Verified 2 days ago